ALFA FinderBSE filing, NSE: MANIPALHOS. Summary written from the filing by ALFA Finder's alert engine.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹677.05
- Market cap
- ₹89,058 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Earnings Call Transcript: Key Takeaways
Q2 revenue ₹3,400 Cr (+37% YoY), EBITDA ₹882 Cr (+30%), 26% margin, volume-led. Eastern government-scheme volumes fell; Sayadri margin recovery is the main story. Management gave no EBITDA guidance.
Manipal Health Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹3,399 Cr (+37.3%), EBITDA ₹882 Cr (+29.8%), margin 26.0%, PAT ex-exceptions ₹380 Cr (+21.6%). Growth is volume-led, helped by Sahyadri consolidation.
Manipal Health Enterprises Q2 FY27 Results: Net Profit ₹285 Cr, Down 10.3% YoY
Manipal Health Enterprises Ltd reported revenue from operations of ₹3,399 Cr (+37.3% YoY) and net profit of ₹285 Cr (-10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹285 Cr · -10.3% YoY
Manipal Health Enterprises Capacity Expansion
Manipal Health Enterprises executed a 29-year-11-month land lease with TIL Investments to build and operate a hospital in Gurugram. No monetary value is disclosed.
- Execution
- 29 years 11 months
Manipal Health Enterprises Board Meeting Date
Manipal Health Enterprises gave notice that its board meets on 13 November 2026 to approve the Q2 and H1 FY27 standalone and consolidated unaudited results. This is advance intimation, and the agenda is proposed only.
Manipal Health Enterprises Legal & Regulatory
Manipal Health's subsidiary received two GST orders imposing penalties totalling about Rs 4.61 Crore. The company says the orders are appealable and the impact is not material.
- Value
- ₹4.61 Cr
Other other announcement announcements
All →Panafic Industrials Other Announcement
Panafic reports full utilisation of Rs.41.06 crore rights issue proceeds with nil deviation. This is the final Monitoring Agency Report for the quarter ended September 30, 2026.
LAPL Automotive Other Announcement
LAPL Automotive reports no deviation in IPO fund utilisation for the half year to September 2026. Rs.1,956 lakh of the Rs.3,239.62 lakh proceeds remains unutilised.
CapitalNumbers Infotech Other Announcement
Capitalnumbers Infotech's Reg 32 statement shows Rs 4,339.73 lakh of IPO proceeds utilised and Rs 4,128.87 lakh unutilised. Allocations were revised by shareholder resolution.
Caliber Mining and Logistics Other Announcement
Caliber Mining filed CARE Ratings' monitoring report on IPO proceeds for July to September 2026. The report records no deviation from the stated objects of the issue.
Kaushalya Logistics Other Announcement
Kaushalya Logistics submitted its half-yearly related party transactions disclosure for the period ended September 30, 2026. Figures are not stated in the letter.
Kshitij Polyline Other Announcement
Kshitij Polyline's monitoring agency report shows no deviation in rights-issue fund use for the quarter ended September 30, 2026. The issue was revised down to ₹18.98 crore.